{"disease":{"id":"coronavirus-disease-2019-covid-19","name":"coronavirus disease 2019 covid 19"},"drugs":{"marketed":[{"drug_id":"tocilizumab","indication_name":"Coronavirus Disease 2019 (COVID-19)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Roactemra","generic_name":"tocilizumab","company_name":"Roche","drug_phase":"marketed","molecular_target":"Interleukin-6 receptor","drug_class":"Interleukin-6 Receptor Antagonist [EPC]","quality_score":10,"revenue":null,"mechanism":"Roactemra works by blocking the interleukin-6 receptor, a protein that plays a key role in inflammation."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04327206","title":"BCG Vaccination to Protect Healthcare Workers Against COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":6828,"lead_sponsor_name":"Murdoch Childrens Research Institute","has_results":false},{"nct_id":"NCT04375761","title":"COVID-19: Human Epidemiology and Response to SARS-CoV-2","phase":"","overall_status":"COMPLETED","enrollment_count":5599,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04545047","title":"Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":5044,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT05594147","title":"An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or Sorafenib","phase":"","overall_status":"COMPLETED","enrollment_count":4103,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05722665","title":"Convolutional Neural Network Model to Detect Coronavirus Disease 2019 (COVID-19) Pneumonia in Chest Radiographs","phase":"","overall_status":"COMPLETED","enrollment_count":3599,"lead_sponsor_name":"Fundacion Clinica Valle del Lili","has_results":false},{"nct_id":"NCT05534074","title":"University Hospital of Ioannina COVID-19 (Coronavirus Disease 2019) Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"University Hospital, Ioannina","has_results":false},{"nct_id":"NCT04443712","title":"Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19)","phase":"","overall_status":"UNKNOWN","enrollment_count":1900,"lead_sponsor_name":"Samia Girgis","has_results":false},{"nct_id":"NCT04508023","title":"A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1284,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT04378777","title":"Immunophenotyping Assessment in a COVID-19 Cohort","phase":"","overall_status":"COMPLETED","enrollment_count":1227,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT07089680","title":"A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT04394117","title":"Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":787,"lead_sponsor_name":"The George Institute","has_results":false},{"nct_id":"NCT05364671","title":"Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":771,"lead_sponsor_name":"Materia Medica Holding","has_results":true},{"nct_id":"NCT05492227","title":"SARS-CoV-2 Nucleic Acid Detection Kit Clinical Performance Study","phase":"","overall_status":"COMPLETED","enrollment_count":607,"lead_sponsor_name":"TransGen Biotech Co., LTD","has_results":false},{"nct_id":"NCT06189040","title":"Immunogenicity After COVID-19 Vaccines in Adapted Schedules","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":580,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT05364268","title":"Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation","phase":"","overall_status":"COMPLETED","enrollment_count":514,"lead_sponsor_name":"AudibleHealth AI, Inc.","has_results":false},{"nct_id":"NCT05007080","title":"A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":304,"lead_sponsor_name":"Janssen Vaccines & Prevention B.V.","has_results":true},{"nct_id":"NCT04898166","title":"Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Syeda Mahanum Ali","has_results":true},{"nct_id":"NCT04403932","title":"Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Hospital San Carlos, Madrid","has_results":false},{"nct_id":"NCT05184062","title":"A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":272,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT05375760","title":"A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":251,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04588363","title":"COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C","phase":"","overall_status":"COMPLETED","enrollment_count":244,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04317040","title":"Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":234,"lead_sponsor_name":"Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT04894409","title":"Evaluation of Silver Nanoparticles for the Prevention of COVID-19","phase":"NA","overall_status":"COMPLETED","enrollment_count":231,"lead_sponsor_name":"Cluster de Bioeconomia de Baja California, A.C","has_results":false},{"nct_id":"NCT04742725","title":"A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":231,"lead_sponsor_name":"Prothione, LLC","has_results":false},{"nct_id":"NCT06305793","title":"RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Kanecia Obie Zimmerman","has_results":false},{"nct_id":"NCT04344977","title":"Collection of Anti-SARS-CoV-2 Immune Plasma","phase":"","overall_status":"COMPLETED","enrollment_count":151,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04341116","title":"Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"I-Mab Biopharma US Limited","has_results":true},{"nct_id":"NCT04473170","title":"Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"Abu Dhabi Stem Cells Center","has_results":false},{"nct_id":"NCT04409509","title":"Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"CSL Behring","has_results":true},{"nct_id":"NCT05659602","title":"A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":111,"lead_sponsor_name":"Beijing Ditan Hospital","has_results":false},{"nct_id":"NCT05437289","title":"A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04951323","title":"Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"University of Liege","has_results":false},{"nct_id":"NCT04391309","title":"COVID-19 and Anti-CD14 Treatment Trial","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":49,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04375397","title":"Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT06735300","title":"Saliva PCR in Pregnant Women with COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"National Cheng-Kung University Hospital","has_results":false},{"nct_id":"NCT04483375","title":"Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Sinocelltech Ltd.","has_results":false},{"nct_id":"NCT04429529","title":"Safety of TY027, a Treatment for COVID-19, in Humans","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Tychan Pte Ltd.","has_results":false},{"nct_id":"NCT04374526","title":"Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT04516564","title":"A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Akesobio Australia Pty Ltd","has_results":false},{"nct_id":"NCT04877743","title":"Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222","phase":"","overall_status":"TERMINATED","enrollment_count":27,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04389840","title":"Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":27,"lead_sponsor_name":"Jazz Pharmaceuticals","has_results":true},{"nct_id":"NCT04644120","title":"Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT04713878","title":"Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia","phase":"NA","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Kanuni Sultan Suleyman Training and Research Hospital","has_results":false},{"nct_id":"NCT04649515","title":"Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"Tychan Pte Ltd.","has_results":false},{"nct_id":"NCT04275245","title":"Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Tang-Du Hospital","has_results":false},{"nct_id":"NCT04389944","title":"Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT05091723","title":"TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Theravance Biopharma","has_results":false},{"nct_id":"NCT04638634","title":"Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"CSL Behring","has_results":false},{"nct_id":"NCT05077969","title":"Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Leidos Life Sciences","has_results":true},{"nct_id":"NCT05077332","title":"LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Leidos Life Sciences","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}